Inpharma Weekly

, Volume 1506, Issue 1, pp 9–9 | Cite as

Alemtuzumab superior to IFN-β-1a for relapsing-remitting MS

Media release


Multiple Sclerosis Interferon Medium Release Purpura Alemtuzumab 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2005

Personalised recommendations